Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Burkitt Lymphoma

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Burkitt Lymphoma:

Pubmed Logo
Pitfalls in diagnostic hematopathology - Part II.
The overlapping features of malignant lymphomas create a diagnostic "grey...
18th November, 2009
Department of Pathology, University of Maryland School of Medicine Int J Clin Exp Pathol. 2009 Sep 10;3(1):39-46.
Differentiating HIV-associated non-Hodgkin's lymphomas with similar plasmacellular differentiation.
Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO)...
17th November, 2009
Department of Pathology, Baystate Medical Center, Tufts School of J HIV Ther. 2009 Jun;14(2):24-33.
Lymphoid and histiocytic proliferations in HIV-positive patients: problems in diagnosis.
Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO)...
17th November, 2009
J HIV Ther. 2009 Jun;14(2):21-3.
B-cell lymphoma associated with Sjogren's syndrome among Japanese patients: a clinicopathologic and immunohistochemical study of 15 cases.
To clarify the clinicopathological findings of B-cell lymphoma associated...
13th November, 2009
Department of Anatomic Diagnostic Pathology, Dokkyo University School of J Clin Exp Hematop. 2009 Nov;49(2):89-95.
[Lymphoid lesions of the head and neck.]
Lymphoid lesions of the head and neck mainly affect four regions:...
11th November, 2009
Laboratoire d'anatomie et cytologie pathologiques, hopital Ann Pathol. 2009 Sep;29(4):323-34. Epub 2009 Sep 22.
DOI Direct Link

View more research publications.

Press Releases About Burkitt Lymphoma:

BioPortfolio Logo
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 19th November, 2009 AEGERA THERAPEUTICS INC.
MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. announced today the dosing of the first patient in a randomized Phase 2B study of AEG35156, a targeted antisense therapeutic in mid-stage
These Patients Need Your Help This Thanksgiving 17th November, 2009 New York Blood Center
NEW YORK, Nov. 17 /PRNewswire-USNewswire/ -- As we approach Thanksgiving, "Black Friday" and the holiday season, New York Blood Center (NYBC) calls upon the community to please remember the
Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology 12th November, 2009 Pharmacyclics, Inc.
SUNNYVALE, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that posters related to PCI-24781 and PCI-32765 have been selected for presentation at the 51st
Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib and ONX 0803 at 51st American Society of Hematology Annual Meeting 10th November, 2009 Onyx Pharmaceuticals, Inc.
-- Abstract # 302 -- PX-171-004, an Ongoing Open-Label, Phase II Study of Single-Agent Carfilzomib (CFZ) in Patients with Relapsed or Refractory Myeloma (MM); Updated
Reportlinker Adds Cancer Non-Hodgkin Lymphoma 10th November, 2009 Reportlinker
-- Maintain a critical competitive advantage. To order this report: Cancer Non-Hodgkin Lymphoma http://www.reportlinker.com/p0161834/Cancer-Non-Hodgkin-Lymphoma.html#utm_source=prnewswire&

BioNews Results for Burkitt Lymphoma:

RSS Logo
BioPortfolio Logo
Benefit event supports student undergoing cancer treatment
Mountain Home News:  Nov 20 2009 12:40PM Matching: burkitt lymphoma
MCHS grad loses battle with cancer November 18
Craig Daily Press:  Nov 19 2009 2:13AM Matching: burkitt lymphoma
MCHS grad loses battle with cancer
Craig Daily Press:  Nov 19 2009 2:13AM Matching: burkitt lymphoma
MCHS grad loses battle with cancer
Steamboat Pilot & Today:  Nov 18 2009 7:44AM Matching: burkitt lymphoma
Boy shares birthday gifts with fellow cancer patients
News 14:  Nov 16 2009 9:09PM Matching: burkitt lymphoma
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Burkitt Lymphoma Patents:

USPTO Logo
US Patent No.Title
7592356 Triazoles as farnesyl transferase inhibitors
7598419 Compounds for modulating cell proliferation
7599933 Coupled two-way clustering analysis of data
7601332 Vitamin receptor binding drug delivery conjugates
7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Burkitt Lymphoma scientists - we have details of around 882 individuals working on Burkitt Lymphoma .


This page has been viewed 566 times
Recent Search Terms used to find this page: burkitt lymphoma 2009 november | PETAL trial Lymphoma | burkits lymphom | burkitt lymphoma 2009 | burkitt lymphoma 2009 | burkitt lymphoma 2009 | burkits lymphoma | burkits lymphomia | burkit lyphoma and death | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Burkitt Lymphoma across BioPortfolio, or for Burkitt Lymphoma Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.